Onconephrology Updates: Immune Checkpoint Inhibitors and Kidney Injury
freecme000
Published on Oct 28, 2022
A Mount Sinai Beth Israel Department of Medicine Grand Rounds presented by Naoka Murakami, MD, PhD, Assistant Professor of Medicine, Harvard Medical School
Category
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
01:20:15Harnessing the Power of Immune Tolerance in Living-Donor Kidney Transplant
47 views 868 days ago -
Watch Later
29:03Abbal Koirala, MD - Rituximab in the management of MCD and immune mediated FSGS
47 views 863 days ago -
Watch Later
44:53Renal Masses: Inpatient and Outpatient Evaluations (and Updates in Renal Cell Carcinoma)
49 views 1338 days ago -
Watch Later
![SGLT2 Inhibitors in Type 2 DM: A Cardiorenal "Game-Changer"]()
53:09SGLT2 Inhibitors in Type 2 DM: A Cardiorenal "Game-Changer"
48 views 1341 days ago -
Watch Later
![Nicolae Leca, MD - Immune Monitoring – Path to Individualizing Immunosuppression in Transplantation]()
29:13
